No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Fisher & Paykel Healthcare Corp Ltd: FPH to announce full year results on 28 May 2025
Trump 2.0: Macquarie's Take on the Winners and Losers in Australian Healthcare
Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk
Should I Buy Fisher & Paykel or ResMed Shares?
Fisher & Paykel Shrugs off Red Thursday as Investors Satisfied Tariff Risks Under Control
Fisher & Paykel Expects Higher Costs in Fiscal 2026 Due to New US Tariffs; Shares Fall 5%